FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/07/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
ST13
US500000079412583Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
David M. Abrahams Webster, Chamberlain & Bean, LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable electronic educational and professional publications, namely, newsletters, fact sheets, and brochures about a biomedical and scientific research facility; downloadable electronic educational and professional podcasts and webcasts featuring information about biomedical and scientific research on human health and human diseases.
Classe 16
Printed educational and professional publications, namely, printed newsletters, fact sheets, and brochures about biomedical and scientific research and information about biomedical and scientific research on human health and human diseases.
Classe 35
Promoting research in the field of human health and human diseases through the support and coordination of research projects conducted by universities, hospitals, research foundations and businesses; business consultation services in the nature of providing assistance in the field of commercialisation of products and services by identifying routes to market for research; business assistance, management and administration services; advisory, consultancy and information services relating to all the aforesaid; compilation of scientific, medical and clinical information into computer databases; collection of business data in connection with clinical trials for business purposes.
Classe 36
Charitable fundraising; charitable fundraising collections; organisation of collections in the nature of charitable fundraising; charitable services, namely, provision of funding for research, education, prevention and treatment of illnesses and human diseases; financial grant services, namely, providing grants for research, education, prevention, and treatment of illnesses and human diseases; provision of funding for charities in the nature of philanthropic services concerning monetary donations; charitable foundation services, namely, provision of funding for medical trials; charitable foundation services, namely, provision of funding for educational and research posts; intellectual property venture fund development and formation services for others enabling inventors of new technology to secure appropriate funding for continued technological development; technology transfer services, namely, financial asset management in the nature of managing revenue from partnered or developed intellectual property; advisory, consultancy and information services relating to all the aforesaid.
Classe 41
Providing educational, training and mentoring services concerning the causes, prevention, detection, diagnosis, and treatment of diseases through educational conferences, seminars and written materials disseminated in connection therewith; providing educational conferences, seminars, and webinars in the field of the causes, prevention, detection, diagnosis, and treatment of diseases and dissemination of printed educational materials therewith; providing educational conferences, seminars, and webinars in the field of the causes, prevention, detection, diagnosis, and treatment of diseases and dissemination of online educational materials therewith; publishing including online publishing of journal articles, press releases, white papers and books; advisory, consultancy and information services relating to all the aforesaid.
Classe 42
Scientific, medical and clinical research services; scientific research and scientific analysis in the field of biotechnology; scientific research and scientific analysis in the field of biochemistry; scientific research and scientific analysis in the field of biology; conducting clinical trials for others; data mining; data security consultancy services; data encryption services; database design and development; maintenance of computer software for databases; mathematical modelling services; scientific and technological services, namely, scientific research and analysis in the field of bioinformatics; drug discovery services; laboratory research in the field of medicine; computer programming and software design services; scientific research and development in the field of medical technology; research on the development and adaptation of health technology and health-related outcomes associated with implementation of health technology; clinical research services, namely, calibration, analysis and reporting of data in connection with clinical trials; conducting clinical trials for others for diagnostic tests and for pharmaceutical preparations; providing temporary use of non-downloadable web-based computer software for data integration, exchange, and analysis; providing biomedical and scientific information in the field of human health and diseases; technology transfer services, namely new product design and development services; scientific research and development services; antibody humanization services, namely antibody engineering in the nature of antibody research and development services; biopharmaceutical product development; biologic assay product development; medical research, namely, preclinical research; clinical research in the in the fields of genetic disorders, infectious diseases and rare diseases; consulting services for others in the design, planning, and implementation of project management of clinical trials; testing and inspection of pharmaceuticals in the nature of pharmacovigilance, namely, monitoring the effects of medical drugs after they have been licensed for use; advisory, consultancy and information services relating to all the aforesaid.
Classe 44
Pharmaceutical treatment diagnostics in the nature of medical and pharmaceutical consultation; medical services; advice on medical information relating to alleviation, diagnosis, prevention and treatment of illnesses and human diseases; advisory, consultancy and information services relating to all the aforesaid.
Classe 45
Legal services; licensing of technology, namely, patent licensing; licensing and intellectual property services in relation to technology transfer services, namely, consulting in the field of intellectual property; advisory, consultancy and information services relating to all the aforesaid.
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/07/2026
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/06/2026
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/05/2026
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
18/05/2026
NOTICE OF REGISTRATION CONFIRMATION EMAILED
28/04/2026
REGISTERED-PRINCIPAL REGISTER
28/04/2026
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/03/2026
PUBLISHED FOR OPPOSITION
10/03/2026
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2026
APPROVED FOR PUB - PRINCIPAL REGISTER
13/02/2026
EXAMINER'S AMENDMENT ENTERED
13/02/2026
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/02/2026
EXAMINERS AMENDMENT E-MAILED
13/02/2026
EXAMINERS AMENDMENT -WRITTEN
13/02/2026
TEAS/EMAIL CORRESPONDENCE ENTERED
05/02/2026
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2026
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/02/2026
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/01/2026
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/01/2026
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/01/2026
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/01/2026
REFUSAL PROCESSED BY IB
18/10/2025
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/09/2025
REFUSAL PROCESSED BY MPU
26/09/2025
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/08/2025
NON-FINAL ACTION WRITTEN
14/08/2025
ASSIGNED TO EXAMINER
13/08/2025
APPLICATION FILING RECEIPT MAILED
12/08/2025
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/08/2025
NEW REPRESENTATIVE AT IB RECEIVED
07/02/2025
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/12/2024
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.